South Korea is aiming to take a leading position in the globally blossoming gene therapy space, and around 20 clinical trials in this area are currently underway in the country, although there has been only one domestic approval so far amid various ongoing regulatory restrictions.
While the amount of clinical activity is increasing at home, local companies’ global programs appear to be progressing more rapidly,...







